TGFB2 and central nervous system cancer: In a recent study that employed a microarray-based gene expression platform, we found that TGFB2 mRNA levels were selectively amplified in primary tumor samples from 29 pediatric DIPG patients compared to normal samples and primary tumor samples from low-grade glioma patients [39].